Guidance: COVID-19: guidance on protecting people defined on medical grounds as extremely vulnerable
Information for protecting people defined on medical grounds as extremely vulnerable from coronavirus (COVID-19).
Information for protecting people defined on medical grounds as extremely vulnerable from coronavirus (COVID-19).
Information for employers about the COVID-19 vaccination programme.
PHE and Porton Biopharma Limited have committed to being more transparent with the public about when, how and why we use animals in research.
A data linkage approach to assessing the contribution of hospital-associated SARS-CoV-2 infection to care home outbreaks in England, 30 January to 12 October 2020.
An epidemiological study comparing the health of those exposed to nuclear weapons tests, to a group of personnel not exposed to radiation.
Form (E53) for genome sequencing for SARS-CoV-2.
Evaluation of the first national ‘Cervical Screening Saves Lives’ campaign which ran in 2019.